organ testing

R&D

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

News

Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T cell engagers from China's Sino Biopharma.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.